Global Gene Therapy in CNS Disorder Market Research Report 2025(Status and Outlook)

March 2025 | 200 pages | ID: G22E38CB1FF6EN
Bosson Research

Abstracts

Report Overview

Gene therapy entails the specific transfer of genetic information into affected cells and tissues in order to restore function in diseased areas.

This report provides a deep insight into the global Gene Therapy in CNS Disorder market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy in CNS Disorder Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy in CNS Disorder market in any manner.

Global Gene Therapy in CNS Disorder Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Voyager Therapeutics

Spark Therapeutics

Novartis AG

Bluebird Bio Inc.

Biogen

Market Segmentation (by Type)

Viral Gene Therapy

Non-viral Gene Therapy

Market Segmentation (by Application)

Alzheimer's Disease

Huntington's Disease

Parkinson's Disease

Batten Disease

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Gene Therapy in CNS Disorder Market
• Overview of the regional outlook of the Gene Therapy in CNS Disorder Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy in CNS Disorder Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Therapy in CNS Disorder
1.2 Key Market Segments
1.2.1 Gene Therapy in CNS Disorder Segment by Type
1.2.2 Gene Therapy in CNS Disorder Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Gene Therapy in CNS Disorder Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Therapy in CNS Disorder Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gene Therapy in CNS Disorder Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Gene Therapy in CNS Disorder Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy in CNS Disorder Product Life Cycle
3.3 Global Gene Therapy in CNS Disorder Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy in CNS Disorder Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy in CNS Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy in CNS Disorder Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Gene Therapy in CNS Disorder Manufacturing Sites, Area Served, Product Type
3.8 Gene Therapy in CNS Disorder Market Competitive Situation and Trends
3.8.1 Gene Therapy in CNS Disorder Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy in CNS Disorder Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Gene Therapy in CNS Disorder Industry Chain Analysis
4.1 Gene Therapy in CNS Disorder Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Therapy in CNS Disorder Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy in CNS Disorder Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Gene Therapy in CNS Disorder Market
5.7 ESG Ratings of Leading Companies
6 Global Gene Therapy in CNS Disorder Market by Region
6.1 Global Gene Therapy in CNS Disorder Market Size by Region
6.1.1 Global Gene Therapy in CNS Disorder Market Size by Region
6.1.2 Global Gene Therapy in CNS Disorder Market Size Market Share by Region
6.2 Global Gene Therapy in CNS Disorder Sales by Region
6.2.1 Global Gene Therapy in CNS Disorder Sales by Region
6.2.2 Global Gene Therapy in CNS Disorder Sales Market Share by Region
7 North America Market Overview
7.1 North America Gene Therapy in CNS Disorder Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Gene Therapy in CNS Disorder Market Size by Type
7.3 North America Gene Therapy in CNS Disorder Market Size by Application
8 Europe Market Overview
8.1 Europe Gene Therapy in CNS Disorder Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Gene Therapy in CNS Disorder Market Size by Type
8.3 Europe Gene Therapy in CNS Disorder Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Gene Therapy in CNS Disorder Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Gene Therapy in CNS Disorder Market Size by Type
9.3 Asia-Pacific Gene Therapy in CNS Disorder Market Size by Application
10 South America Market Overview
10.1 South America Gene Therapy in CNS Disorder Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Gene Therapy in CNS Disorder Market Size by Type
10.3 South America Gene Therapy in CNS Disorder Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Gene Therapy in CNS Disorder Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Gene Therapy in CNS Disorder Market Size by Type
11.3 Middle East and Africa Gene Therapy in CNS Disorder Market Size by Application
12 Gene Therapy in CNS Disorder Market Production by Region
12.1 Global Production of Gene Therapy in CNS Disorder by Region(2020-2025)
12.2 Global Gene Therapy in CNS Disorder Revenue Market Share by Region (2020-2025)
12.3 Global Gene Therapy in CNS Disorder Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Gene Therapy in CNS Disorder Production
12.4.1 North America Gene Therapy in CNS Disorder Production Growth Rate (2020-2025)
12.4.2 North America Gene Therapy in CNS Disorder Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Gene Therapy in CNS Disorder Production
12.5.1 Europe Gene Therapy in CNS Disorder Production Growth Rate (2020-2025)
12.5.2 Europe Gene Therapy in CNS Disorder Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Gene Therapy in CNS Disorder Production (2020-2025)
12.6.1 Japan Gene Therapy in CNS Disorder Production Growth Rate (2020-2025)
12.6.2 Japan Gene Therapy in CNS Disorder Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Gene Therapy in CNS Disorder Production (2020-2025)
12.7.1 China Gene Therapy in CNS Disorder Production Growth Rate (2020-2025)
12.7.2 China Gene Therapy in CNS Disorder Production, Revenue, Price and Gross Margin (2020-2025)
13 Gene Therapy in CNS Disorder Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Gene Therapy in CNS Disorder Sales Market Share by Type (2020-2033)
13.3 Global Gene Therapy in CNS Disorder Market Size Market Share by Type (2020-2033)
13.4 Global Gene Therapy in CNS Disorder Price by Type (2020-2033)
14 Gene Therapy in CNS Disorder Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Gene Therapy in CNS Disorder Market Sales by Application (2020-2033)
14.3 Global Gene Therapy in CNS Disorder Market Size (M USD) by Application (2020-2033)
14.4 Global Gene Therapy in CNS Disorder Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Voyager Therapeutics
15.1.1 Voyager Therapeutics Basic Information
15.1.2 Voyager Therapeutics Gene Therapy in CNS Disorder Product Overview
15.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Product Market Performance
15.1.4 Voyager Therapeutics Business Overview
15.1.5 Voyager Therapeutics SWOT Analysis
15.1.6 Voyager Therapeutics Recent Developments
15.2 Spark Therapeutics
15.2.1 Spark Therapeutics Basic Information
15.2.2 Spark Therapeutics Gene Therapy in CNS Disorder Product Overview
15.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Product Market Performance
15.2.4 Spark Therapeutics Business Overview
15.2.5 Spark Therapeutics SWOT Analysis
15.2.6 Spark Therapeutics Recent Developments
15.3 Novartis AG
15.3.1 Novartis AG Basic Information
15.3.2 Novartis AG Gene Therapy in CNS Disorder Product Overview
15.3.3 Novartis AG Gene Therapy in CNS Disorder Product Market Performance
15.3.4 Novartis AG Business Overview
15.3.5 Novartis AG SWOT Analysis
15.3.6 Novartis AG Recent Developments
15.4 Bluebird Bio Inc.
15.4.1 Bluebird Bio Inc. Basic Information
15.4.2 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Overview
15.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Market Performance
15.4.4 Bluebird Bio Inc. Business Overview
15.4.5 Bluebird Bio Inc. Recent Developments
15.5 Biogen
15.5.1 Biogen Basic Information
15.5.2 Biogen Gene Therapy in CNS Disorder Product Overview
15.5.3 Biogen Gene Therapy in CNS Disorder Product Market Performance
15.5.4 Biogen Business Overview
15.5.5 Biogen Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapy in CNS Disorder Market Size by Type (M USD)
Table 4. Global Gene Therapy in CNS Disorder Market Size by Application (M USD)
Table 5. Gene Therapy in CNS Disorder Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapy in CNS Disorder Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy in CNS Disorder Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapy in CNS Disorder Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapy in CNS Disorder Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in CNS Disorder as of 2024)
Table 11. Global Market Gene Therapy in CNS Disorder Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Gene Therapy in CNS Disorder Manufacturing Sites and Area Served
Table 13. Manufacturers Gene Therapy in CNS Disorder Product Type
Table 14. Global Gene Therapy in CNS Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy in CNS Disorder Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Gene Therapy in CNS Disorder Market Size Comparison by Region (M USD)
Table 26. Global Gene Therapy in CNS Disorder Market Size by Region (2020-2033) & (M USD)
Table 27. Global Gene Therapy in CNS Disorder Market Size Market Share by Region (2020-2033)
Table 28. Global Gene Therapy in CNS Disorder Sales by Region (2020-2033) & (K MT)
Table 29. Global Gene Therapy in CNS Disorder Sales Market Share by Region (2020-2033)
Table 30. North America Gene Therapy in CNS Disorder Market Size by Country (2020-2033) & (M USD)
Table 31. North America Gene Therapy in CNS Disorder Sales by Country (2020-2033) & (K MT)
Table 32. North America Gene Therapy in CNS Disorder Sales by Type (K MT)
Table 33. North America Gene Therapy in CNS Disorder Market Size by Type (M USD)
Table 34. North America Gene Therapy in CNS Disorder Sales (K MT) by Type (2020-2033)
Table 35. North America Gene Therapy in CNS Disorder Market Size (M USD) by Type (2020-2033)
Table 36. North America Gene Therapy in CNS Disorder Sales by Application (K MT)
Table 37. North America Gene Therapy in CNS Disorder Market Size by Application (M USD)
Table 38. North America Gene Therapy in CNS Disorder Sales (K MT) by Application (2020-2033)
Table 39. North America Gene Therapy in CNS Disorder Market Size (M USD) by Application (2020-2033)
Table 40. Europe Gene Therapy in CNS Disorder Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Gene Therapy in CNS Disorder Sales by Country (2020-2033) & (K MT)
Table 42. Europe Gene Therapy in CNS Disorder Sales by Type (K MT)
Table 43. Europe Gene Therapy in CNS Disorder Market Size by Type (M USD)
Table 44. Europe Gene Therapy in CNS Disorder Sales (K MT) by Type (2020-2033)
Table 45. Europe Gene Therapy in CNS Disorder Market Size (M USD) by Type (2020-2033)
Table 46. Europe Gene Therapy in CNS Disorder Sales by Application (K MT)
Table 47. Europe Gene Therapy in CNS Disorder Market Size by Application (M USD)
Table 48. Europe Gene Therapy in CNS Disorder Sales (K MT) by Application (2020-2033)
Table 49. Europe Gene Therapy in CNS Disorder Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Gene Therapy in CNS Disorder Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Gene Therapy in CNS Disorder Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Gene Therapy in CNS Disorder Sales by Type (K MT)
Table 53. Asia-Pacific Gene Therapy in CNS Disorder Market Size by Type (M USD)
Table 54. Asia-Pacific Gene Therapy in CNS Disorder Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Gene Therapy in CNS Disorder Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Gene Therapy in CNS Disorder Sales by Application (K MT)
Table 57. Asia-Pacific Gene Therapy in CNS Disorder Market Size by Application (M USD)
Table 58. Asia-Pacific Gene Therapy in CNS Disorder Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Gene Therapy in CNS Disorder Market Size (M USD) by Application (2020-2025)
Table 60. South America Gene Therapy in CNS Disorder Market Size by Country (2020-2033) & (M USD)
Table 61. South America Gene Therapy in CNS Disorder Sales by Country (2020-2033) & (K MT)
Table 62. South America Gene Therapy in CNS Disorder Sales by Type (K MT)
Table 63. South America Gene Therapy in CNS Disorder Market Size by Type (M USD)
Table 64. South America Gene Therapy in CNS Disorder Sales (K MT) by Type (2020-2033)
Table 65. South America Gene Therapy in CNS Disorder Market Size (M USD) by Type (2020-2033)
Table 66. South America Gene Therapy in CNS Disorder Sales by Application (K MT)
Table 67. South America Gene Therapy in CNS Disorder Market Size by Application (M USD)
Table 68. South America Gene Therapy in CNS Disorder Sales (K MT) by Application (2020-2033)
Table 69. South America Gene Therapy in CNS Disorder Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Gene Therapy in CNS Disorder Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Gene Therapy in CNS Disorder Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Gene Therapy in CNS Disorder Sales by Type (K MT)
Table 73. Middle East and Africa Gene Therapy in CNS Disorder Market Size by Type (M USD)
Table 74. Middle East and Africa Gene Therapy in CNS Disorder Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Gene Therapy in CNS Disorder Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Gene Therapy in CNS Disorder Sales by Application (K MT)
Table 77. Middle East and Africa Gene Therapy in CNS Disorder Market Size by Application (M USD)
Table 78. Middle East and Africa Gene Therapy in CNS Disorder Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Gene Therapy in CNS Disorder Market Size (M USD) by Application (2020-2033)
Table 80. Global Gene Therapy in CNS Disorder Production (K MT) by Region(2020-2025)
Table 81. Global Gene Therapy in CNS Disorder Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Gene Therapy in CNS Disorder Revenue Market Share by Region (2020-2025)
Table 83. Global Gene Therapy in CNS Disorder Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Gene Therapy in CNS Disorder Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Gene Therapy in CNS Disorder Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Gene Therapy in CNS Disorder Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Gene Therapy in CNS Disorder Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Gene Therapy in CNS Disorder Sales by Type (K MT)
Table 89. Global Gene Therapy in CNS Disorder Market Size by Type (M USD)
Table 90. Global Gene Therapy in CNS Disorder Sales (K MT) by Type (2020-2033)
Table 91. Global Gene Therapy in CNS Disorder Sales Market Share by Type (2020-2033)
Table 92. Global Gene Therapy in CNS Disorder Market Size (M USD) by Type (2020-2033)
Table 93. Global Gene Therapy in CNS Disorder Market Size Share by Type (2020-2033)
Table 94. Global Gene Therapy in CNS Disorder Sales (K MT) by Application
Table 95. Global Gene Therapy in CNS Disorder Market Size by Application(M USD)
Table 96. Global Gene Therapy in CNS Disorder Sales by Application (2020-2033) & (K MT)
Table 97. Global Gene Therapy in CNS Disorder Sales Market Share by Application (2020-2033)
Table 98. Global Gene Therapy in CNS Disorder Market Size by Application (2020-2033) & (M USD)
Table 99. Global Gene Therapy in CNS Disorder Market Share by Application (2020-2033)
Table 100. Global Gene Therapy in CNS Disorder Sales Growth Rate by Application (2020-2033)
Table 101. Voyager Therapeutics Basic Information
Table 102. Voyager Therapeutics Gene Therapy in CNS Disorder Product Overview
Table 103. Voyager Therapeutics Gene Therapy in CNS Disorder Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Voyager Therapeutics Business Overview
Table 105. Voyager Therapeutics SWOT Analysis
Table 106. Voyager Therapeutics Recent Developments
Table 107. Spark Therapeutics Basic Information
Table 108. Spark Therapeutics Gene Therapy in CNS Disorder Product Overview
Table 109. Spark Therapeutics Gene Therapy in CNS Disorder Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Spark Therapeutics Business Overview
Table 111. Spark Therapeutics SWOT Analysis
Table 112. Spark Therapeutics Recent Developments
Table 113. Novartis AG Basic Information
Table 114. Novartis AG Gene Therapy in CNS Disorder Product Overview
Table 115. Novartis AG Gene Therapy in CNS Disorder Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Novartis AG Business Overview
Table 117. Novartis AG SWOT Analysis
Table 118. Novartis AG Recent Developments
Table 119. Bluebird Bio Inc. Basic Information
Table 120. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Overview
Table 121. Bluebird Bio Inc. Gene Therapy in CNS Disorder Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Bluebird Bio Inc. Business Overview
Table 123. Bluebird Bio Inc. Recent Developments
Table 124. Biogen Basic Information
Table 125. Biogen Gene Therapy in CNS Disorder Product Overview
Table 126. Biogen Gene Therapy in CNS Disorder Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Biogen Business Overview
Table 128. Biogen Recent Developments
List of Figures
Figure 1. Product Picture of Gene Therapy in CNS Disorder
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy in CNS Disorder Market Size (M USD), 2024-2033
Figure 5. Global Gene Therapy in CNS Disorder Market Size (M USD) (2020-2033)
Figure 6. Global Gene Therapy in CNS Disorder Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy in CNS Disorder Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy in CNS Disorder Product Life Cycle
Figure 13. Gene Therapy in CNS Disorder Sales Share by Manufacturers in 2024
Figure 14. Global Gene Therapy in CNS Disorder Revenue Share by Manufacturers in 2024
Figure 15. Gene Therapy in CNS Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gene Therapy in CNS Disorder Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy in CNS Disorder Revenue in 2024
Figure 18. Industry Chain Map of Gene Therapy in CNS Disorder
Figure 19. Global Gene Therapy in CNS Disorder Market PEST Analysis
Figure 20. Global Gene Therapy in CNS Disorder Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Gene Therapy in CNS Disorder Market Size by Region
Figure 27. Global Gene Therapy in CNS Disorder Market Size Market Share by Region (2020-2033)
Figure 28. Global Gene Therapy in CNS Disorder Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Gene Therapy in CNS Disorder Market Size (M USD) by Country
Figure 33. USA Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Gene Therapy in CNS Disorder Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Gene Therapy in CNS Disorder Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Gene Therapy in CNS Disorder Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Gene Therapy in CNS Disorder Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Gene Therapy in CNS Disorder Market Size (M USD)by Type
Figure 40. North America Gene Therapy in CNS Disorder Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Gene Therapy in CNS Disorder Market Size (M USD) by Country
Figure 45. Germany Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Gene Therapy in CNS Disorder Market Size (M USD) by Type
Figure 56. Europe Gene Therapy in CNS Disorder Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Gene Therapy in CNS Disorder Market Size (M USD) by Country
Figure 61. China Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Gene Therapy in CNS Disorder Market Size (M USD) by Type
Figure 72. Asia-Pacific Gene Therapy in CNS Disorder Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Gene Therapy in CNS Disorder Market Size (M USD) by Country
Figure 77. Brazil Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Gene Therapy in CNS Disorder Market Size (M USD) by Type
Figure 84. South America Gene Therapy in CNS Disorder Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Gene Therapy in CNS Disorder Market Size (M USD) by Country
Figure 89. Saudi Arabia Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Gene Therapy in CNS Disorder Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Gene Therapy in CNS Disorder Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Gene Therapy in CNS Disorder Market Size (M USD) by Type
Figure 100. Middle East and Africa Gene Therapy in CNS Disorder Market Size (M USD) by Application
Figure 101. Global Gene Therapy in CNS Disorder Production Market Share by Region (2020-2025)
Figure 102. North America Gene Therapy in CNS Disorder Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Gene Therapy in CNS Disorder Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Gene Therapy in CNS Disorder Production (K MT) Growth Rate (2020-2025)
Figure 105. China Gene Therapy in CNS Disorder Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Gene Therapy in CNS Disorder Market Size by Type (M USD)
Figure 108. Sales Market Share of Gene Therapy in CNS Disorder by Type (2020-2033)
Figure 109. Sales Market Share of Gene Therapy in CNS Disorder by Type in 2024
Figure 110. Market Size Share of Gene Therapy in CNS Disorder by Type (2020-2033)
Figure 111. Market Size Share of Gene Therapy in CNS Disorder by Type in 2024
Figure 112. Global Gene Therapy in CNS Disorder Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Gene Therapy in CNS Disorder Market Size by Application(M USD)
Figure 115. Global Gene Therapy in CNS Disorder Market Share by Application
Figure 116. Global Gene Therapy in CNS Disorder Sales Market Share by Application (2020-2033)
Figure 117. Global Gene Therapy in CNS Disorder Sales Market Share by Application in 2024
Figure 118. Global Gene Therapy in CNS Disorder Market Share by Application (2020-2033)
Figure 119. Global Gene Therapy in CNS Disorder Market Share by Application in 2024
Figure 120. Global Gene Therapy in CNS Disorder Sales Growth Rate by Application (2020-2033)